Inspire Medical rebounds as J.P. Morgan defends after Lilly sleep data [Seeking Alpha]
JP Morgan Chase & Co. (JPM)
Last jp morgan chase & co. earnings: 4/14 06:43 am
Check Earnings Report
US:NYSE Investor Relations:
jpmorganchase.com/corporate/investor-relations/investor-relations.htm
Company Research
Source: Seeking Alpha
Morgan defended the stock after Eli Lilly ( LLY ) said its weight loss therapy Zepbound succeeded in a mid-stage trial for patients with obstructive sleep apnea. According to J.P. Morgan's Robbie Marcus, LLY's readout was not strong enough to indicate a threat to replace breathing machines and sleep apnea devices like the ones Inspire ( INSP ) markets. The MedTech company commercializes the Inspire system, a minimally invasive solution designed to treat OSA patients. It competes in a market dominated by ResMed ( RMD ) and Philips ( PHG ), which manufacture mask-like CPAP devices for OSA. Marcus thinks that Zepbound, a dual GIP and GLP-1 receptor agonist also marketed as Mounjaro for diabetes, could play a complementary role in treating OSA. He argued that the readout was positive for Inspire Medical ( INSP ), as the data aligned with expectations. “This clears an overhang for the stock and allows investors to return to focusing on the 1Q fundamentals, which we think should be
Show less
Read more
Impact Snapshot
Event Time:
JPM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JPM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JPM alerts
High impacting JP Morgan Chase & Co. news events
Weekly update
A roundup of the hottest topics
JPM
News
- Family offices are looking beyond the stock market for higher returns, new report finds [MSNBC.com]MSNBC.com
- SUNRATE partners with YeePay to empower Chinese companies to navigate global expansion [Yahoo! Finance]Yahoo! Finance
- JPMorgan-backed Brazilian digital bank C6 posts first-ever profit in Q1 [Reuters]Reuters
- 1 Wall Street Analyst Thinks Alphabet Stock Is Going to $200. Is It a Buy? [Yahoo! Finance]Yahoo! Finance
- Palisade Capital Management Welcomes Chris Mashia to Small Cap Core and Smid Cap Core Equity Strategies [Yahoo! Finance]Yahoo! Finance
JPM
Earnings
- 4/12/24 - Beat
JPM
Sec Filings
- 4/29/24 - Form 424B2
- 4/29/24 - Form 424B2
- 4/29/24 - Form 424B2
- JPM's page on the SEC website